Come up with a name for your new list and we'll add to it:
ProteoTech raised a round of funding on August 16, 2004. Investors include
Small Business Innovation Research Awards.
ProteoTech is a private drug development company focused on targeting amyloid diseases. ProteoTech is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of…